Mediterr J Rheumatol 2017;28(3):147-52
Can rheumatologists diagnose and manage Giant Cell Arteritis better than non-rheumatologists? The Maltese Experience
Authors Information

Department of Rheumatology, Mater Dei Hospital, Malta

  1. Borchers A T, Gershwin M E. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmune Rev 2012;11:A544-54.
  2. Baslund B et al. Mortality in patients with giant cell arteritis. Rheumatology 2015;54:139-43.
  3. Jakobsson K et al. Body mass index and the risk of giant cell arteritis- results from a prospective study. Rheumatology 2015;54:433-40.
  4. Petri H et al. Incidence of Giant Cell Arteritis and characteristics of patients: Data-driven analysis of comorbidities. Arthritis Care Res 2015;67:390-5.
  5. Mohammad J et al. Incidence and mortality rates of biopsy proven GCA in southern Sweden. Ann Rheumatic Dis 2015; 74:993-7.
  6. Mollan S P et al. Increase in admissions related to giant cell arteritis and polymyalgia rheumatic in the UK, 2002-13 without a decrease in associated sight loss: potential implications to service provision. Rheumatology 2015;54:375-7.
  7. Singh Abha J et al. Visual manifestations in GCA: Trend over five decades in a population-based cohort. J. Rheumatology 2015 Feb; 42:309-15.
  8. Baskhar D et al. BSR and BHPR guidelines for management of Giant Cell Arteritis; Rheumatology 2010;49:1594-7.
  9. Demographic Review 2013- Valletta: National Statistics Office, 2015.
  10. Mohammad A J et al. Ann Rheum Dis. 2015;74:993-7.
  11. Grossman C et al. Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy. Clin Rheumatol 2016;35:1817.
  12. Mukhtyar C et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 68:318-23.
  13. Labarca C et al. Predictors of relapse and treatment outcomes in a biopsy-proven giant cell arteritis: a retrospective cohort study. Rheumatology 2016;55:347-56.
  14. Smith R et al. Is Mycophenolate Mofetil effective in the treatment of large vessel vasculitis? Ann Rheum Dis 2015;74:525.
  15. Unizony S et al. Tocilizumab for treatment of large-vessel vasculitis (GCA, Takayasu’s arteritis) and Polymyalgia Rheumatica. Arthritis Care Res 2012;64:1720-9.
  16. Jakobbson K et al. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis. BMC Musculoskeletal Disorders 2016;Aug 24.
  17. Kermani T, Schmidt J, Crowson C S, Ytterberg S R, Hunder G G, Matteson E, et al. Utility of Erythrocyte Sedimentation Rate and C-reactive protein for the Diagnosis of Giant Cell Arteritis. Semin Arthritis Rheum 2012;41:866-71.